Elizabeth Yeu Lin
CIK 1842190 · Chief Medical Officer · last filed 2026-03-19
Elizabeth Yeu Lin is a Chief Medical Officer who has filed 28 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for TARS, was dated Mar 19, 2026. Across all open-market trades the lifetime net is +$271.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.59M
2
28
$271.6K
Holdings By Company
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | TARS | Notice (144) | −390 | -$26.1K | EDGAR |
| 2026-03-19 | TARS | Sell (S) | −1,144 | -$78.2K | EDGAR |
| 2026-03-18 | TARS | Notice (144) | −379 | -$26.0K | EDGAR |
| 2026-03-17 | TARS | Notice (144) | −375 | -$26.0K | EDGAR |
| 2026-03-17 | TARS | Exer (M) | +2,511 | $0 | EDGAR |
| 2026-03-09 | TARS | Grant (A) | — | $0 | EDGAR |
| 2025-12-17 | TARS | Mixed | +4,741 | -$165.2K | EDGAR |
| 2025-12-16 | TARS | Notice (144) | −2,078 | -$165.2K | EDGAR |
| 2025-06-20 | STAA | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | TARS | Mixed | +2,344 | -$41.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.